规格
|
Alternate Agonists:
|
Progesterone |
Antagonists:
|
RU 486 |
Assay Entry:
|
Cell-based beta lactamase reporter gene |
Cell Line:
|
293T (HEK) |
Cell State:
|
Division-Arrested Cells |
Druggable Target:
|
Nuclear Receptors |
Gene Symbol:
|
RXRβ |
Primary Agonist:
|
R5020 |
Product Line:
|
GeneBLAzer® |
Reporter Gene:
|
BLA (Beta-Lactamase) |
System Type:
|
GeneBLAzer™ |
Target Entry:
|
RXR beta, NR2B2, RXRB |
Detection Method:
|
Fluorescent |
储存
|
Shipping: Dry IceStorage: -80°C/Liquid NitrogenSufficient division-arrested cells and substrate to assay one 384-well plate. Includes:RXR beta HEK 293T DA cells (K1405A)LiveBLAzer™-FRET B/G Loading Kit, 70 μg |
GeneBLAzer®RXR beta DA (Division Arrested) cells and RXR beta-UAS-bla HEK 293T cells contain the ligand-binding domain (LBD) of the human Retinoid X Receptor beta (RXR beta) fused to the DNA-binding domain of GAL4 stably integrated in the GeneBLAzer®UAS-bla HEK 293T cell line. GeneBLAzer®UAS-bla HEK 293T cells stably express a beta-lactamase reporter gene under the transcriptional control of an upstream activator sequence (UAS). When an agonist binds to the LBD of the GAL4 (DBD)-RXR beta (LBD) fusion protein, the protein binds to the UAS, resulting in expression of beta-lactamase. DA cells are irreversibly division arrested using a low-dose treatment of Mitomycin-C, and have no apparent toxicity or change in cellular signal transduction. Both RXR beta DA cells and RXR beta-UAS-bla HEK 293T cells are functionally validated for Z' and EC50 concentrations of 9-cis retinoic acid (9-cis-RA). In addition, RXR beta-UAS-bla HEK 293T cells have been tested for assay performance under variable conditions, including DMSO concentration, cell number, and stimulation time.